Home > News > Calando Pharmaceuticals Will Jointly Develop RNAi Therapeutics
February 22nd, 2006
Calando Pharmaceuticals Will Jointly Develop RNAi Therapeutics
Abstract:
NCI To Co-Sponsor ‘Nanotechnology for Cancer Prevention, Diagnosis and Treatment’ Symposium at Nanotech 2006 Conference in Boston.
Source:
NSTI
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||